γ-secretase inhibitor up-regulates vascular endothelial growth factor receptor-2 and endothelial nitric oxide synthase

Experimental and Therapeutic Medicine

Volumn 2, Issue 4, 2011, Pages 725-729

  Zou, Yu Hui ^a   Cao, Yi Qun ^a   Wang, Lai Xing ^a   Zhang, Yu Hui ^a   Yue, Zhi Jian ^a   Liu, Jian Min ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Endothelial nitric oxide synthase; Vascular endothelial growth factor receptor

Indexed keywords

ANGIOGENESIS INHIBITOR; DIMETHYL SULFOXIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA SECRETASE INHIBITOR; N [N (3,5 DIFLUOROPHENACETYL)ALANYL]PHENYLGLYCINE TERT BUTYL ESTER; PHOSPHOTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 2 KINASE INHIBITOR; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ARTICLE; DRUG MECHANISM; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 79958038230     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.257     Document Type: Article

References (10)

1. Masuda S, Kumano K, Suzuki T, et al: Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model. Cancer Sci 100: 2444-2450, 2009.
2. Caiado F, Real C, Carvalho T and Dias S: Notch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potential. PLoS One 3: e3752, 2008.
3. Cook KM and Figg W D: Angiogenesis inhibitors: cur rent strategies and future prospects. CA Cancer J Clin 60: 222-243, 2010.
4. Michel T and Vanhoutte PM: Cellular signaling and NO production. Pfugers Arch 459: 807-816, 2010.
5. Toda N, Ayajiki K and Okamura T: Interaction of endothelial nitric oxide and angiotensin in the circulation. Pharmacol Rev 59: 54-87, 2007.
6. Hirashima M: Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling. Anat Sci Int 84: 95-101, 2009.
7. Shawber CJ, Funahashi Y, Francisco E, et al: Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin Invest 117: 3369-3382, 2007.
8. Kroll J and Waltenberger J: VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252: 743-746, 1998.
9. Wang Y, Nagase S and Koyama A: Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phos-phorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway. Nitric Oxide 10: 25-35, 2004.
10. Facemire CS, Nixon AB, Griffths R, Hurwitz H and Coffman TM: Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. Hypertension 54: 652-658, 2009.